Mar 02 2024
Psilocybin has “both short-term and long-term antidepressant effects and holds promise as a potential complementary or alternative therapy for depression”, according to a new study. The study was published in the recent issue of the journal Frontiers in Psychiatry, as well as published online by the US National Library of Medicine. It was conducted by …
Feb 29 2024
Consuming marijuana via inhalation was effective in providing migraine relief, according to a study published online by the National Library of Medicine. For this randomized, double-blind, placebo-controlled, crossover trial, researchers at the University of California examined 92 patients with persistent migraines. Patients treated up to four separate migraine attacks, “one each with vaporized 1) 6% …
Feb 18 2024
Results of a newly published study indicate “a real-life positive effect of CBD on alternating hemiplegia of childhood type spells.” Many alternating hemiplegia of childhood (AHC) patients have received Cannabidiol (CBD) but, to our knowledge, there are no published data available”, states the abstract of the study, which was published by the European Journal of …
Feb 18 2024
In a new study published in the journal Med, psilocybin was found to be safe and effective in combatting treatment resistant depression. Titled Psilocybin-assisted psychotherapy for treatment resistant depression: A randomized clinical trial evaluating repeated doses of psilocybin, the study was conducted by researchers at the University of Toronto, McMaster University and Queens University. “Psilocybin-assisted …
Feb 06 2024
Cananbidiol (CBD) may be a useful tool for combatting periodontitis, according to a new placebo-controlled, double-blind, randomized clinical trial. Published by the Journal of Periodontal Research, the study was conducted by researchers at Palacky University, the University Hospital Olomouc, Masaryk University and the Institute of Chemical Process Fundamentals of the Czech Academy of Sciences, all …
Feb 02 2024
According to a new study published in the journal Neurotherapeutics, “CBD is a potential candidate to ameliorate intraventricular hemorrhage-induced immature brain damage.” The study found that CBD “reduced IVH-induced brain damage and its short- and long-term consequences, showing robust and pleiotropic neuroprotective effects” in an animal model. “Intraventricular hemorrhage (IVH) is an important cause of …
Feb 01 2024
According to a new study marijuana does not lead to an increase in motor vehicle accidents, with “high self-reported acute cannabis use” actually associated with lower odds of such accidents. Published in the journal Accident Analysis and Prevention, the study was conducted by researchers at the Oregon Health & Science University, the University of Colorado …
Jan 25 2024
Psilocybin mushrooms “could prove to be revolutionary in treating depression and become an alternative medication to SSRI”, finds a new study. Titled Psilocybin, an Effective Treatment for Major Depressive Disorder in Adults – A Systematic Review, the study was published in the journal Clinical Psychopharmacology and Neuroscience. The study was conducted by researchers at Keele …
Jan 25 2024
According to a new study, a strong majority of those in Canada support legislation legalizing the medical use of psilocybin, while an even higher percent support its use for end-of-life care. Titled Social acceptability of psilocybin-assisted therapy for existential distress at the end of life: A population-based survey, the study is published in the journal …
Jan 25 2024
Treatment with a spray containing both CBD and THC “does not impair skills relevant to driving in those patients with tic disorders”, according to a new study. The study found that not only did the spray not impair skills, it “even improved fitness to drive in a subset of patients who were unfit to drive …
